Alpha-Isopropyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide (naphthypramide, DA 992): a new anti-inflammatory agent. II. Antipyretic, analgesic and C.N.S. depressant activity.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000633:toxicity; D001831:Body Temperature / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D003315:Cornea / Q000502:physiology; D004357:Drug Synergism; D004431:Ear, External / Q000502:physiology; D006591:Hexobarbital / Q000494:pharmacology; D008615:Mephenesin / Q000494:pharmacology; D009068:Movement / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D012018:Reflex
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D008615:Mephenesin; D006591:Hexobarbital; D010653:Phenylbutazone